• OPEN AN ACCOUNT
Indian Indices
Nifty
25,522.50 61.20
(0.24%)
Sensex
83,712.51 270.01
( 0.32%)
Bank Nifty
57,256.30 307.10
( 0.54%)
Nifty IT
38,983.25 116.30
( 0.30%)
Global Indices
Nasdaq
44,419.70 -429.83
(-0.96%)
Dow Jones
6,250.56 -49.79
(-0.79%)
Hang Seng
39,701.12 113.44
(0.29%)
Nikkei 225
8,854.18 47.65
(0.54%)
Forex
USD-INR
84.98 -0.45
(-0.53%)
EUR-INR
100.05 -0.56
(-0.55%)
GBP-INR
115.91 -0.68
(-0.58%)
JPY-INR
0.59 0.00
(-0.66%)

EQUITY - MARKET SCREENER

Fermenta Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
506414
INE225B01021
129.1446643
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
14.77
998.59
EPS(TTM)
Face Value()
Div & Yield %
22.97
5
0
 

Astal Laboratories standalone net profit rises 389.29% in the March 2025 quarter
May 20,2025
Net profit of Astal Laboratories rose 389.29% to Rs 2.74 crore in the quarter ended March 2025 as against Rs 0.56 crore during the previous quarter ended March 2024. Sales rose 91.59% to Rs 23.47 crore in the quarter ended March 2025 as against Rs 12.25 crore during the previous quarter ended March 2024.

For the full year,net profit rose 1044.87% to Rs 8.93 crore in the year ended March 2025 as against Rs 0.78 crore during the previous year ended March 2024. Sales rose 171.59% to Rs 64.23 crore in the year ended March 2025 as against Rs 23.65 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales23.4712.25 92 64.2323.65 172
OPM %17.774.73 -19.884.69 -
PBDT3.940.58 579 12.201.11 999
PBT3.840.56 586 11.981.08 1009
NP2.740.56 389 8.930.78 1045